DexCom (DXCM) Misses Q4 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $77.94 -0.49%
Revenue Growth %: +9.9%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +9.9%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
